Infectious Disease Expert Amesh Adalja and Epidemiologist Keri Althoff appeared weekly on Bloomberg QuickTake's 'QuickTake Charge' to share their thoughts on the latest news and findings surrounding the COVID-19 pandemic in the U.S. and globally.
You can view previous Bloomberg QuickTake segments below.
Omicron BA.2 subvariant gains ground in U.S.
Amesh Adalja, MD, discusses the BA.2 subvariant circulating in the U.S. and the potential risks it may pose to the population.
Divided global pandemic response
Amesh Adalja, MD, discusses the roll back of various mitigation measures and vaccine mandates across the U.S., explaining these restrictions should be tied to relevant data such as hospitalizations, which are unlikely to surge again due to population immunity and key antivirals and treatments.
Hong Kong faces worst outbreak on record for China
Amesh Adalja, MD, discusses the latest COVID outbreak in Hong Kong, emphasizing the importance of addressing vaccine hesitancy, particularly among elderly and other vulnerable populations
White House warns that COVID funding is drying up
Keri Althoff, associate professor of Epidemiology, discusses the White House funding for pandemic preparedness, as well as what living with COVID will look like in the coming weeks/months.
What to expect from COVID's next six months
Amesh Adalja, MD, discusses the next six months of the COVID pandemic and what the "new normal" will look like depending on people's risk tolerance.
CDC studies advice for easing mask rules
Keri Althoff, associate professor of Epidemiology, discusses certain areas easing mitigation strategies, such as masking, as COVID cases and hospitalizations start to decline across the U.S.
Democratic-led states revisit mask mandates
Amesh Adalja, MD, explains population immunity, discussing what mitigation strategies can be rolled back as the pandemic is seemingly moving towards an endemic state.
Pfizer seeks clearance for COVID shot in young kids
Amesh Adalja, MD, discusses the expected timeline for children under five to begin receiving COVID vaccines.
Can States or Companies Issue Vaccine Mandates?
Amesh Adalja, MD, discusses employer vaccine mandates after the Supreme Court's rejection of a vaccine-or-test federal rule.
Nations worldwide reconsider COVID-19 restrictions
Keri Althoff discusses the latest outlook on Omicron and coronavirus restrictions as we start to see case numbers decrease globally.
On year into Biden's presidency
Amesh Adalja discusses the how the changing COVID-19 guidance throughout the pandemic has influenced people's perception.
Omicron deaths in South Africa peaked at 15% of delta
Keri Althoff, associate professor of Epidemiology, discusses the trend in COVID cases, hospitalizations, and surges across the country.
Biden team looks to ramp up testing
Amesh Adalja, MD, discusses the importance of testing throughout the pandemic and the role it will play in moving COVID to an endemic state.
US sees most COVID hospital patients since pandemic onset
Keri Althoff, associate professor of Epidemiology, discusses the trends in COVID cases throughout the U.S. and the importance of tracking this data.
Pandemic expectations for 2022
Amesh Adalja, MD, discusses pandemic expectations for 2022 as the Omicron variant continues to spread.
The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News. (Source: Bloomberg)